Age group | Sampling (n) | Type 2 diabetes | Overweight and obesityd | Hypertensionc | |||||
---|---|---|---|---|---|---|---|---|---|
Survey | OGTT | Previously identified %a | Newly identified %b | Total diabetes % | Pre- diabetes %b | 25 ≤ BMI < 30 % | BMI ≥ 30 % | SBP ≥ 140 or DBP ≥ 90 or current meds | |
Men | |||||||||
20–29 | 585 | 141 | 1.9 | 2.8 | 4.7 | 22.3 | 37.6 | 38.0 | 5.7 |
30–39 | 519 | 118 | 4.8 | 9.7 | 14.5 | 27.4 | 39.3 | 44.9 | 13.9 |
40–49 | 405 | 103 | 13.1 | 11.8 | 24.9 | 32.9 | 37.4 | 50.3 | 25.6 |
50–59 | 351 | 22 | 18.2 | 14.9 | 33.1 | 44.6 | 38.0 | 45.3 | 44.4 |
60–69 | 254 | 12 | 22.8 | 19.3 | 42.1 | 38.6 | 29.5 | 51.9 | 70.5 |
70+ | 208 | 12 | 24.5 | 25.2 | 49.7 | 44.0 | 37.6 | 55.3 | 79.5 |
Totals | 2322 | 408 | 11.8c | 11.9c | 23.7c | 32.8c | 37.0c | 46.2c | 32.1c |
Women | |||||||||
20–29 | 707 | 263 | 1.4 | 1.9 | 3.3 | 28.5 | 31.9 | 41.1 | 2.7 |
30–39 | 615 | 310 | 3.4 | 7.5 | 10.9 | 39.1 | 32.4 | 47.4 | 5.3 |
40–49 | 565 | 279 | 10.3 | 10.0 | 20.2 | 40.5 | 29.8 | 57.3 | 21.7 |
50–59 | 434 | 38 | 24.9 | 9.9 | 34.8 | 35.6 | 30.3 | 59.6 | 50.6 |
60–69 | 298 | 32 | 32.9 | 25.2 | 58.1 | 16.3 | 35.6 | 45.0 | 71.2 |
70+ | 289 | 13 | 29.8 | 32.4 | 62.2 | 21.6 | 30.9 | 46.9 | 84.8 |
Totals | 2908 | 935 | 14.4c | 12.3c | 26.7c | 31.9c | 31.5c | 49.5c | 32.4c |
p value | 0.062 | 0.594 | 0.276 | 0.807 | 0.000 | 0.018 | 0.046 | ||
♂vs♀ and ORe | 0.85 | 1.05 | 1.19 | 1.01 | 1.28 | 0.88 | 1.16 |